The goal of this initiative is to increase the number of investigators committed to research in pulmonary diseases by equipping these new investigators with the necessary skills for genetics and genomics research to study complex genetic disease. Our approach to meeting the intent of this initiative is train Scholars in genomics research using the integrated facilities of the Center for Human Genetics and the Division of Pulmonary, Critical Care and Immunologic Diseases in conjunction with one of two already established Master's Degree Programs (Health Sciences Research or Molecular Medicine) which includes a year of research. This curriculum will be supplemented with additional laboratory rotations to train Scholars in the fundamentals of genetics and genomics research. Finally, all Scholars will participate in career development and active research under the mentorship of two faculty supervisors with the goal of publications in peer reviewed journals and the development of independent scientific research skills. We have a strong integrated Center for Human Genomics which is well-funded with a strong emphasis on respiratory genetics, primarily genetics of asthma and, secondary, genetics of COPD. Ten faculty within the Genomics Center have their primary academic appointment in the Pulmonary Section. Currently, postdoctoral fellows have one year of full time research during their clinical training. This training grant would permit these pulmonary trainees to apply for full time research in genomics and pulmonary medicine while completing a masters degree over a two to three year period. Thus, the program can be integrated with the current pulmonary training program to support an additional research training to develop the skills necessary to become an independent physician scientist. Others may enter this program with a PhD with emphasis on respiratory research and will be able to develop skills in genomics research, thus, facilitating research directions and career development.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Physician Scientist Award (Program) (PSA) (K12)
Project #
Application #
Study Section
Special Emphasis Panel (ZHL1-CSR-A (S1))
Program Officer
Colombini-Hatch, Sandra
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Wake Forest University Health Sciences
Other Health Professions
Schools of Medicine
United States
Zip Code
Ortega, Victor E; Hawkins, Gregory A; Moore, Wendy C et al. (2014) Effect of rare variants in ADRB2 on risk of severe exacerbations and symptom control during longacting ? agonist treatment in a multiethnic asthma population: a genetic study. Lancet Respir Med 2:204-13
Miller, Stacey M; Ortega, Victor E (2013) Pharmacogenetics and the development of personalized approaches for combination therapy in asthma. Curr Allergy Asthma Rep 13:443-52
Slager, Rebecca E; Otulana, Babatunde A; Hawkins, Gregory A et al. (2012) IL-4 receptor polymorphisms predict reduction in asthma exacerbations during response to an anti-IL-4 receptor ýý antagonist. J Allergy Clin Immunol 130:516-22.e4
Bleecker, Eugene R; Siler, Thomas; Owen, Roger et al. (2011) Bronchodilator efficacy and safety of indacaterol 150 ?g once daily in patients with COPD: an analysis of pooled data. Int J Chron Obstruct Pulmon Dis 6:431-8
Pascual, Rodolfo M; Peters, Stephen P (2011) Asthma. Med Clin North Am 95:1115-24
Moore, Wendy C; Pascual, Rodolfo M (2010) Update in asthma 2009. Am J Respir Crit Care Med 181:1181-7
Slager, Rebecca E; Simpson, Sean L; Levan, Tricia D et al. (2010) Rhinitis associated with pesticide use among private pesticide applicators in the agricultural health study. J Toxicol Environ Health A 73:1382-93
Slager, Rebecca E; Hawkins, Gregory A; Ampleford, Elizabeth J et al. (2010) IL-4 receptor ? polymorphisms are predictors of a pharmacogenetic response to a novel IL-4/IL-13 antagonist. J Allergy Clin Immunol 126:875-8
Pascual, Rodolfo M; Peters, Stephen P (2009) The irreversible component of persistent asthma. J Allergy Clin Immunol 124:883-90;quiz 891-2